The investigation was led by Jiali Yu, Jianing Shi, Xuan Wu, Weina Xu, Weifang Dai and Qingli Zhou of Zhejiang University’s Fourth Affiliated Hospital and International School of Medicine in Yiwu, China. The team set out to answer a deceptively simple question: if physical activity lowers the risk of cardiovascular disease, and if it also lowers the risk of depression, does depression sit on the causal pathway between the two? Answering that question rigorously requires more than a simple correlation. Depression is known to cluster with unhealthy lifestyles, smoking, obesity and socioeconomic disadvantage, all of which independently affect the heart. Untangling whether depressed mood itself mediates the exercise–heart relationship demands both large observational datasets and methods capable of probing causality.

For the observational component, the researchers turned to the U.S. National Health and Nutrition Examination Survey, or NHANES, drawing on six consecutive survey cycles from 2007 to 2018. After applying careful inclusion and exclusion criteria, they assembled a cohort of 23,729 American adults, each of whom had provided information on physical activity levels, depressive symptoms and physician-diagnosed cardiovascular conditions, alongside a rich panel of demographic, lifestyle and clinical covariates. Physical activity was assessed using validated questionnaire instruments modeled on the Global Physical Activity Questionnaire framework, allowing participants to be categorized by their weekly volume of moderate and vigorous activity. Depressive symptoms were screened with the Patient Health Questionnaire-9, or PHQ-9, a nine-item instrument whose accuracy for detecting major depression has been confirmed in large individual-participant meta-analyses. Cardiovascular disease status, including coronary heart disease, congestive heart failure, heart attack and stroke, was captured through the survey’s Medical Condition Questionnaire.

The statistical approach was deliberately conservative. The team used weighted multivariable logistic regression, incorporating NHANES’s complex survey design weights so that the results generalize to the civilian, non-institutionalized U.S. population. Models adjusted for age, sex, race and ethnicity, body mass index, smoking status, alcohol consumption, poverty income ratio, education, the Healthy Eating Index, and laboratory measures including HDL cholesterol, LDL cholesterol and triglycerides. Restricted cubic splines were employed to detect non-linear dose–response patterns. The headline observational findings were striking in their symmetry: compared with participants reporting low physical activity, those in the high-activity group had 23 percent lower odds of depressive symptoms and 23 percent lower odds of cardiovascular disease. The spline analysis revealed a U-shaped relationship between activity and depressive symptoms, hinting that the mood benefits of exercise may plateau or even reverse at extreme volumes, a pattern consistent with reports of overtraining and exercise dependence in the sports medicine literature.

Observational associations, however compelling, cannot by themselves establish that physical activity causes lower depression or that depression causes heart disease. Reverse causation looms large: people with early, undiagnosed heart disease may become sedentary and depressed simultaneously. To break this deadlock, the researchers deployed two-sample Mendelian randomization, a technique that exploits the random allocation of genetic variants at conception as a natural experiment. The underlying logic is elegant. Because genetic variants inherited from parents are, in principle, independent of later-life confounders such as diet, income or smoking, they can serve as instruments to estimate causal effects. The team drew summary statistics from genome-wide association studies, or GWAS, conducted among individuals of European ancestry, including the large Nature Genetics consortium analysis of physical activity and sedentary behavior, GWAS of depression phenotypes from UK Biobank, and GWAS data on cardiovascular outcomes. Single-nucleotide polymorphisms strongly associated with each trait were selected as instrumental variables, and inverse-variance weighted analysis provided the primary causal estimates.

The genetic results corroborated the observational picture. Genetically predicted higher physical activity was associated with lower genetic liability to depression, with an odds ratio of 0.96 per increment of genetically influenced activity, and a 95 percent confidence interval of 0.94 to 0.98. Genetically predicted physical activity was likewise associated with lower liability to cardiovascular disease, with an odds ratio of 0.97 and a confidence interval of 0.95 to 0.98. Perhaps most tellingly, genetically increased liability to depression was associated with a higher risk of cardiovascular disease, with an odds ratio of 1.11 and a confidence interval of 1.06 to 1.16. In other words, the genetic data suggested a causal chain in which greater activity reduces depression, and depression itself raises cardiovascular risk. Robustness checks, including sensitivity analyses for horizontal pleiotropy, where genetic variants influence outcomes through pathways unrelated to the exposure of interest, and for heterogeneity across instrument estimates, supported the stability of the findings.

Bringing both strands together, the formal mediation analysis indicated that depressive symptoms constitute a small but statistically significant indirect pathway linking physical activity to cardiovascular disease. The proportion of the total effect explained by this pathway is modest, and the authors are explicit that its clinical relevance should be interpreted cautiously. Physical activity almost certainly protects the heart through many parallel mechanisms, including improved blood pressure, enhanced endothelial function, favorable lipid profiles, better glucose regulation, reduced systemic inflammation and direct effects on cardiac structure and molecular signaling, as recent reviews of exercise’s molecular mediators have detailed. Depression mediation represents one tributary in a much larger river. Still, identifying it matters, because it suggests that interventions targeting mood could amplify the cardiovascular benefits of exercise, and that screening for depressive symptoms in cardiology and primary care settings may carry preventive value beyond mental health alone.

The biological plausibility of a depression–heart connection is well established in the literature. Depression has been associated with autonomic nervous system dysfunction, including elevated heart rate and reduced heart rate variability, as well as dysregulation of the hypothalamic–pituitary–adrenal axis and chronic low-grade inflammation. Shared immunometabolic pathways, including insulin resistance and pro-inflammatory cytokine activity, appear to underpin both conditions, and genetic studies have documented common variants linking age-related diseases. Exercise, meanwhile, modulates many of these same systems, boosting effector neurotransmitters such as serotonin, dopamine and brain-derived neurotrophic factor, improving sleep, and dampening inflammatory signaling. Clinical trials in patients with coronary heart disease, such as the UPBEAT study, have already shown that exercise can rival pharmacotherapy in reducing depressive symptoms, lending real-world weight to the mechanistic chain proposed by the new analysis.

The study’s strengths lie in its scale and its dual methodology. Twenty-three thousand seven hundred NHANES participants spanning twelve years provide the statistical power to adjust for a formidable list of confounders, while Mendelian randomization offers a complementary lens that is largely immune to those confounders. The consistency of effect directions across the two approaches, despite their very different assumptions and error structures, strengthens the causal interpretation. The authors also note important limitations. Both the observational and genetic analyses rest on populations of predominantly European ancestry for the GWAS instruments, raising questions about generalizability to other groups, a concern heightened by well-documented racial and ethnic disparities in cardiovascular risk factors within the United States. Physical activity was self-reported, which introduces measurement error, and the mediation effect, while statistically significant, is small. Residual confounding in the observational models cannot be fully excluded, and Mendelian randomization estimates reflect lifelong average exposure rather than modifiable change in adulthood.

For the public, the takeaway is refreshingly practical and aligns with World Health Organization 2020 guidelines, which recommend at least 150 to 300 minutes of moderate-intensity aerobic activity per week. Moving more appears to protect not only the heart directly but also the mind, and protecting the mind in turn appears to protect the heart. Clinicians may find in these results a rationale for treating physical activity as a dual-purpose prescription, and for taking depressive symptoms seriously as a modifiable cardiovascular risk factor in their own right. The researchers, whose work was supported by the Zhejiang Provincial Department of Science and Technology Pointman Programme, emphasize that the indirect pathway through depression is one thread in a complex web, and that future longitudinal and intervention studies should test whether treating or preventing depression measurably reduces cardiovascular events in physically active and sedentary populations alike. In the meantime, the message that a brisk daily walk serves both brain and heart has rarely rested on such a firm combination of evidence.

Unlike prior investigations that predominantly relied on cross-sectional data to associate single time-point CVH assessments with health outcomes, this research uniquely incorporates longitudinal trajectory analyses over a 25-year period using data derived from the iconic Framingham Heart Study (FHS). This extended temporal lens allowed investigators to quantify the cumulative burden of suboptimal cardiovascular health beginning in young adulthood and extending into mid-life, thus providing a more robust framework for understanding how early-life health behaviors and biological metrics collectively influence disease risk decades later.

The mean cumulative LE8 score calculated across all 3,231 participants was 65 out of 100, indicating a moderate overall cardiovascular health profile within the cohort. More compellingly, individuals falling within the highest quartile of cumulative LE8 scores—reflecting persistent adherence to optimal cardiovascular health parameters—demonstrated an extraordinary 73% reduction in CVD risk compared to peers situated in the lowest quartile. This stark contrast underscores the powerful protective effect of sustained healthy lifestyle practices and physiological risk factor management over time.

Methodologically, the team utilized data from five examination cycles spaced across 1971 to 1995. For each participant, LE8 scores at these discrete time points were used to construct an area-under-the-curve (AUC) metric, encapsulating the aggregate cardiovascular health exposure over the quarter-century span. Additionally, the researchers calculated individual slopes reflecting the rate of LE8 score change throughout this period, capturing dynamic health transitions rather than static snapshots. By integrating these complex longitudinal metrics with subsequent disease outcome data, the study disentangles how both cumulative burden and recent health status converge to influence disease trajectories.

One of the pivotal revelations from this analysis is the significance of the LE8 score at the final examination cycle (year 25), which served as the baseline for prospective risk assessment. The findings suggest that even after accounting for cumulative cardiovascular health over the previous decades, the most recent CVH status critically predicts future disease risk. Consequently, two individuals with similar long-term LE8 profiles but differing health statuses at year 25 exhibited divergent CVD risk profiles, with the individual manifesting superior recent cardiovascular health having markedly lower risk. This observation highlights the persistent malleability of disease risk contingent on current health behaviors and biometric parameters, providing renewed impetus for lifestyle modification interventions even later in mid-life.

Lead investigators emphasize that these data collectively advocate for routine clinical adoption of the LE8 scoring system as a dynamic tool to measure, monitor, and motivate cardiovascular health improvements over time. Such an approach offers clinicians a quantifiable target to tailor personalized interventions across multiple domains—ranging from nutritional guidance and physical activity promotion to management of metabolic risk factors and smoking cessation—ultimately fostering a paradigm shift toward precision preventive cardiology.

From a mechanistic perspective, the cumulative detrimental effects of elevated BMI, hypertension, dyslipidemia, impaired glucose metabolism, sedentary lifestyle, poor dietary quality, tobacco use, and sleep disturbances likely coalesce to exacerbate endothelial dysfunction, systemic inflammation, and metabolic derangements. These pathophysiological perturbations accelerate atherogenesis and compromise cardiac function, compounding the lifetime risk of adverse cardiovascular events. By quantifying the integrated burden of these factors longitudinally, the LE8 scoring model captures the complex interplay of behavioral and clinical determinants that static score assessments may miss.

Moreover, the inclusion of sleep as a novel component within the LE8 construct reflects emerging evidence implicating sleep quality and duration as pivotal modulators of cardiovascular risk. Poor sleep has been linked to dysregulation of autonomic tone, elevated sympathetic activity, and increased systemic inflammation—all pathways converging on cardiovascular pathology. Integrating this underappreciated dimension into a comprehensive CVH index enhances the predictive fidelity of the LE8 score.

This study’s robust statistical analyses, encompassing area-under-the-curve calculations and slope estimations, exemplify the power of longitudinal epidemiologic methodologies to unravel the temporal dynamics of risk factor exposure. Such sophisticated modeling transcends the limitations of traditional cross-sectional studies, allowing for more informative risk stratification and life-course epidemiological insights.

The implications of these findings extend beyond clinical practice to public health policy realms. Interventions targeting cardiovascular health optimization must commence early in life and persist through mid-adulthood to achieve maximal disease prevention. The study’s results caution against complacency even amidst improvements at later life stages, reinforcing the need for a lifelong commitment to cardiovascular wellness.

Furthermore, this research reaffirms the enduring value of the Framingham Heart Study as a cornerstone dataset enabling transformative discoveries in cardiovascular epidemiology. Longitudinal cohorts with multidecade follow-up and granular phenotyping remain indispensable in decrypting the complex interdependencies between lifestyle, clinical risk factors, and cardiovascular morbidity and mortality.

In summary, this seminal work rigorously evidences that cumulative, sustained excellence in cardiovascular health profoundly diminishes subsequent risk of CVD and mortality. By operationalizing Life’s Essential 8 as a longitudinally integrative metric, clinicians and researchers are equipped with a vital framework to drive precision prevention and promote population-wide cardiovascular resilience.

Subject of Research: People
Article Title: Relating Cumulative Life’s Essential 8 Score With Cardiovascular Disease and Death: The Framingham Heart Study
News Publication Date: April 27, 2026
Web References: http://dx.doi.org/10.1016/j.jacadv.2026.102706
Keywords: cardiovascular health, Life’s Essential 8, Framingham Heart Study, longitudinal study, cumulative risk, preventive cardiology, cardiovascular disease, lifestyle factors, epidemiology

The Life’s Essential 8 is a recently refined set of cardiovascular health metrics developed by the American Heart Association to better gauge heart and brain health. These eight components integrate four health behaviors—diet, physical activity, smoking status, and sleep—and four health factors—body mass index (BMI), cholesterol, blood sugar, and blood pressure. This comprehensive approach allows for nuanced insight into the interplay between lifestyle choices and physiological markers of cardiovascular wellness. Each component is scored on a scale from 0 to 100, with higher scores indicating optimal health. These are averaged to produce an overall cardiovascular health score, where scores below 50 signal low health, between 50 and 79 indicate moderate health, and 80 or above represent high cardiovascular health.

The present study analyzed data from 3,050 adults representative of approximately 37.9 million Americans aged 65 or older. The participants’ cardiovascular status was self-reported, encompassing conditions such as coronary heart disease, stroke, heart failure, high blood pressure, heart-related chest pain, and heart attacks, as well as individuals without any reported cardiovascular condition. This stratification allowed researchers to compare cardiovascular health scores across these subgroups, illuminating the gradient of decline associated with disease burden.

One of the key findings revealed that older adults without diagnosed cardiovascular disease maintained an average cardiovascular health score of 68, classified as moderate health. In stark contrast, individuals living with one or more cardiovascular diseases had scores below 60, with a pronounced tendency for scores to drop as additional cardiovascular conditions accumulated. This dose-response relationship underscores the compounded effect of multiple cardiovascular ailments on overall cardiovascular wellness metrics.

Further analysis uncovered significant declines in cardiovascular health across several disease groups during the years studied. Notably, participants with high blood pressure experienced a 4.1% reduction in their LE8 scores, decreasing from 59.6 in 2013 to 57.1 in 2018. The decline was even more pronounced among those with a history of stroke, who suffered an 11.5% drop from 60.6 to 53.6, and most severe in individuals with heart failure, where scores plummeted by 15.2% from 60.9 down to 51.6. These statistics highlight worsening cardiovascular metrics in a vulnerable and growing demographic segment, intensifying calls for focused preventive and management strategies.

Analysis of specific LE8 components pointed to blood pressure and physical activity as the primary drivers of the health gap between those with and without cardiovascular disease. Lower scores in these areas were consistently observed among participants with cardiovascular conditions, suggesting that therapeutic and lifestyle interventions targeting blood pressure control and increased physical activity could yield significant improvements in cardiovascular health. Effectively, these two modifiable factors disproportionately influence the cardiovascular health inequities evident in older adults.

The study’s implications extend beyond highlighting existing health disparities; they emphasize the urgency of early, sustained intervention. According to study co-author James M. Walker, a medical and business dual-degree student, the research establishes a crucial baseline for the cardiovascular health status of the elderly population before the COVID-19 pandemic, a period during which older adults suffered disproportionately from cardiovascular complications. This foundational insight sets the stage for future longitudinal studies examining how cardiovascular health trajectories have evolved through and beyond the pandemic era.

While aging naturally introduces challenges to maintaining optimal health, the findings underscore that cardiovascular decline is not an inevitable consequence of age alone but is heavily influenced by the presence and number of cardiovascular diseases compounded by lifestyle factors. This insight strengthens the case for proactive health promotion throughout the lifespan, encouraging adherence to Life’s Essential 8 starting from early childhood to foster resilience against cardiovascular deterioration in later years.

The study authors caution readers about the research’s limitations, emphasizing its cross-sectional design which restricts conclusions regarding causality. Data were collected from discrete groups of participants rather than tracking the same individuals over time, limiting definitive interpretations about the progression of cardiovascular health. Furthermore, the study addressed six common cardiovascular disease categories, potentially omitting less prevalent conditions that contribute to cardiovascular health dynamics in this population.

Demographically, the study cohort was predominantly white (79.9%), with representation from Black, Asian, Mexican, Hispanic, and other racial and ethnic groups, reflecting the diverse makeup of the U.S. elderly population. This diversity affirms the study’s relevance to a broad patient demographic but also signals the need for further research to examine cardiovascular health disparities across racial and ethnic lines more deeply.

In light of these findings, healthcare providers are encouraged to intensify efforts to support cardiovascular health in older adults, focusing on blood pressure management and increased physical activity. The American Heart Association’s broader mission advocates for accessible education and community resources designed to empower older individuals to maintain healthier lifestyles and mitigate the progression of cardiovascular diseases. Such initiatives are increasingly vital as the Baby Boomer generation approaches and surpasses the age of 65, heralding a substantial demographic shift with significant public health implications.

Dr. Stacey E. Rosen, volunteer president of the American Heart Association, underscores the significance of this research against the backdrop of a growing elderly population with complex cardiac histories. She emphasizes that medical advances have extended life expectancy, even after major cardiovascular events like heart attacks and strokes, making sustained management essential. By prioritizing early intervention and ongoing support, health systems can enable older adults to maximize quality of life and functionality despite cardiovascular challenges.

Overall, the study reveals a critical aspect of public health, demonstrating that cardiovascular health is deteriorating among older adults afflicted with certain cardiovascular diseases, driven largely by insufficient blood pressure control and low physical activity levels. The insights invite renewed focus on holistic, multidimensional interventions guided by Life’s Essential 8, aiming to gradually reverse these trends and foster better cardiovascular outcomes in the aging population.

Subject of Research: Cardiovascular health trends among older U.S. adults with cardiovascular diseases using Life’s Essential 8 metrics

Article Title: Comparing the “Life’s Essential 8” Scores of Older Adults Living With Cardiovascular Diseases: NHANES, 2013 to 2018

News Publication Date: August 20, 2025

Web References:
– https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8
– https://www.ahajournals.org/journal/jaha
– https://dx.doi.org/10.1161/JAHA.124.039659

References: Article published in the Journal of the American Heart Association, DOI: 10.1161/JAHA.124.039659

Keywords: Cardiovascular disease, cardiovascular health, Life’s Essential 8, blood pressure, physical activity, older adults, NHANES, heart failure, stroke, high blood pressure